Exchange: NASDAQ·Updated 04:00 PM EST

About GDTC

About

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
42

Frequently Asked Questions

Advertisement|Remove ads.